0 Comments
0 Shares
145 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Radiopharmaceutical Theranostics Market: How Is Lutetium-177 PSMA Therapy Transforming Prostate Cancer?Lutetium-177 PSMA radioligand therapy — the targeted radionuclide treatment delivering beta-emitting Lu-177 directly to prostate-specific membrane antigen-expressing prostate cancer cells — represents the most commercially significant radiopharmaceutical theranostics launch in the market's history, with the Radiopharmaceutical Theranostics Market reflecting Lu-177 PSMA as the...0 Comments 0 Shares 83 Views 0 Reviews